APA (7th ed.) Citation

Koblin, B., Metch, B., Morgan, C., Novak, R., Swann, E., Metzger, D., . . . Frank, I. (2012). Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906). Retrovirology, 9(Suppl 2), 1. https://doi.org/10.1186/1742-4690-9-S2-P123

Chicago Style (17th ed.) Citation

Koblin, B., et al. "Feasibility of Recruiting High-risk Women in the US for HIV Vaccine Efficacy Trials (HVTN 906)." Retrovirology 9, no. Suppl 2 (2012): 1. https://doi.org/10.1186/1742-4690-9-S2-P123.

MLA (9th ed.) Citation

Koblin, B., et al. "Feasibility of Recruiting High-risk Women in the US for HIV Vaccine Efficacy Trials (HVTN 906)." Retrovirology, vol. 9, no. Suppl 2, 2012, p. 1, https://doi.org/10.1186/1742-4690-9-S2-P123.